Skip to main content
SpringerLink
Log in
Book cover

Liver Disorders pp 519–529Cite as

Spontaneous Bacterial Peritonitis (SBP)

  • Chapter
  • First Online:

  • 1629 Accesses

Abstract

Spontaneous bacterial peritonitis (SBP) is defined as an infection of ascites fluid, typically in the setting of bacterial gut translocation in patients with cirrhosis and ascites, and without another explanation for peritonitis. SBP is a major source of morbidity and mortality among patients with cirrhosis and requires a high clinical suspicion by the treating practitioner followed by diagnostic paracentesis and prompt initiation of antibiotics to prevent complications. This chapter reviews the pathogenesis and precipitating risk factors leading to the development of SBP, followed by a discussion of clinical presentation and diagnostic evaluation for patients suspected of having SBP. The remainder of the chapter focuses on treatment principles for an acute episode of SBP as well as strategies and guidelines for patients at high risk of SBP who may benefit from prophylaxis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Conn HO. Spontaneous peritonitis and bacteremia in Laennec’s cirrhosis caused by enteric organisms: a relatively common but rarely recognized syndrome. Ann Intern Med. 1964;60(4):568–80.

    Article  CAS  PubMed  Google Scholar 

  2. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120(3):726–48.

    Article  CAS  PubMed  Google Scholar 

  3. McHutchison JG, Runyon BA. Spontaneous bacterial peritonitis. In: Surawicz CM, Owen RL, editors. Gastrointestinal and hepatic infections. Philadelphia, PA: WB Saunders Company; 1994.

    Google Scholar 

  4. Chang C-S et al. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998;28(5):1187–90.

    Article  CAS  PubMed  Google Scholar 

  5. Bauer TM et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol. 2001;96(10):2962–7.

    Article  CAS  PubMed  Google Scholar 

  6. Cirera I et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34(1):32–7.

    Article  CAS  PubMed  Google Scholar 

  7. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18(3):353–8.

    Article  CAS  PubMed  Google Scholar 

  8. Obstein KL et al. Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol. 2007;102(12):2732–6.

    Article  PubMed  Google Scholar 

  9. Bajaj JS et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol. 2009;104(5):1130–4.

    Article  CAS  PubMed  Google Scholar 

  10. Terg R et al. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. J Hepatol. 2015;62:1056.

    Article  CAS  PubMed  Google Scholar 

  11. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology. 1986;91(6):1343–6.

    Article  CAS  PubMed  Google Scholar 

  12. Titó L et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988;8(1):27–31.

    Article  PubMed  Google Scholar 

  13. Rimola A et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology. 1985;5(3):463–7.

    Article  CAS  PubMed  Google Scholar 

  14. Bernard B et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29(6):1655–61.

    Article  CAS  PubMed  Google Scholar 

  15. Fernández J et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007;133(3):818–24.

    Article  PubMed  Google Scholar 

  16. Senkerikova R et al. Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation. J Hepatol. 2014;60(4):773–81.

    Article  CAS  PubMed  Google Scholar 

  17. Such J et al. Low C 3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol. 1988;6(1):80–4.

    Article  CAS  PubMed  Google Scholar 

  18. Bonnel AR, Bunchorntavakul C, Rajender Reddy K. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(9):727–38.

    Article  PubMed  Google Scholar 

  19. Woolf GM, Runyon BA. Spontaneous Salmonella infection of high-protein noncirrhotic ascites. J Clin Gastroenterol. 1990;12(4):430–2.

    Article  CAS  PubMed  Google Scholar 

  20. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis—in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol. 2001;96(4):1232–6.

    CAS  PubMed  Google Scholar 

  21. Orman ES et al. Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol. 2014;12(3):496–503.

    Article  PubMed  Google Scholar 

  22. Grabau CM et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40(2):484–8.

    Article  PubMed  Google Scholar 

  23. Kim JJ et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109(9):1436–42.

    Article  CAS  PubMed  Google Scholar 

  24. De A, Bankar S, Baveja S. Comparison of three culture methods for diagnosis of Spontaneous Bacterial Peritonitis (SBP) in adult patients with cirrhosis. Int J Curr Microbiol Appl Sci. 2014;3(7):156–60.

    Google Scholar 

  25. Runyon BA et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117(3):215–20.

    Article  CAS  PubMed  Google Scholar 

  26. Chavez-Tapia NC, et al. Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients. Cochrane Database Syst Rev 2009; (1): CD002232.

    Google Scholar 

  27. Felisart J et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985;5(3):457–62.

    Article  CAS  PubMed  Google Scholar 

  28. Runyon BA et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology. 1991;100(6):1737–42.

    Article  CAS  PubMed  Google Scholar 

  29. Follo A et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20(6):1495–501.

    Article  CAS  PubMed  Google Scholar 

  30. Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2011;9(3):260–5.

    Article  PubMed  Google Scholar 

  31. Ruiz-del-Arbol L et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2003;38(5):1210–8.

    Article  PubMed  Google Scholar 

  32. Sort P et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403–9.

    Article  CAS  PubMed  Google Scholar 

  33. Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol. 2013;11(2):123–30.

    Article  CAS  PubMed  Google Scholar 

  34. Mandorfer M et al. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 2014;146(7):1680–90.

    Article  CAS  PubMed  Google Scholar 

  35. Ginés P et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12(4):716–24.

    Article  PubMed  Google Scholar 

  36. Soriano G et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology. 1991;100(2):477–81.

    Article  CAS  PubMed  Google Scholar 

  37. Singh N et al. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med. 1995;122(8):595–8.

    Article  CAS  PubMed  Google Scholar 

  38. Rolachon A et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology. 1995;22(4):1171–4.

    CAS  PubMed  Google Scholar 

  39. Chavez-Tapia NC, et al. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010; (9): CD002907.

    Google Scholar 

  40. Carbonell N et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652–9.

    Article  PubMed  Google Scholar 

  41. Khashab MA et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81(1):81.

    Article  PubMed  Google Scholar 

  42. Minuk GY et al. Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations. Dig Dis Sci. 2011;56(4):1235–41.

    Article  CAS  PubMed  Google Scholar 

  43. Rolando N et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol. 1993;18(3):290–4.

    Article  CAS  PubMed  Google Scholar 

  44. Dellinger RP et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.

    Article  CAS  PubMed  Google Scholar 

  45. Su D-H et al. Value of serum procalcitonin levels in predicting spontaneous bacterial peritonitis. Hepatogastroenterology. 2013;60(124):641–6.

    CAS  PubMed  Google Scholar 

  46. Parsi MA et al. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology. 2008;135(3):803–7.

    Article  CAS  PubMed  Google Scholar 

  47. Mendler MH et al. A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method. J Hepatol. 2010;53(3):477–83.

    Article  PubMed  Google Scholar 

  48. Hanouneh MA et al. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis. J Clin Gastroenterol. 2012;46(8):709–15.

    Article  CAS  PubMed  Google Scholar 

  49. Lutz P et al. Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. PLoS One. 2014;9(4):e93909.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology & Hepatology, Department of Medicine, Medical College of Wisconsin, 9200 W. Wisconsin Ave, Milwaukee, WI, 53226, USA

    Adam J. Schiro M.D.

Authors
  1. Adam J. Schiro M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam J. Schiro M.D. .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Medical College of Wisconsin , Milwaukee, Wisconsin, USA

    Kia Saeian

  2. Division of Gastroenterology and Hepatology, Medicine Medical College of Wisconsin , Milwaukee, Wisconsin, USA

    Reza Shaker

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Schiro, A.J. (2017). Spontaneous Bacterial Peritonitis (SBP). In: Saeian, K., Shaker, R. (eds) Liver Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-30103-7_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30103-7_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30101-3

  • Online ISBN: 978-3-319-30103-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation